L

    LENSAR Inc (LNSR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $8.39
    +0.09 (+1.08%)

    Market Cap: $103.08M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    54%(13/24)
    Avg Surprise
    -31.84%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.22
    Range$-0.22 - $-0.22
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-0.22
    Revenue Consensus
    $14M
    Range$14M - $14M
    2 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.08
    Range$-0.08 - $-0.08
    1 analysts
    Revenue Consensus
    $19M
    Range$19M - $19M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.08---
    Sep 26EST
    		-$-0.22---
    Jun 26
    Reported Aug 6
    		$0.10N/A+137.04%Beat+166.7%
    Mar 26
    Reported May 8
    		$-0.20N/A-140.08%Miss-227.3%
    Dec 25
    Reported Mar 31
    		$-0.11$-0.10-7.80%Miss-9.9%
    Sep 25
    Reported Nov 6
    		$-0.11$-0.08-37.50%Miss-22.2%
    Jun 25
    Reported Aug 7
    		$-0.15$-0.07-114.29%Miss-25.0%
    Mar 25
    Reported May 8
    		$-0.06N/A+60.00%Beat+68.4%
    Dec 24
    Reported Feb 27
    		$-0.10$-0.18+45.50%Beat+72.0%
    Sep 24
    Reported Nov 7
    		$-0.09N/A+68.97%Beat+67.9%
    Jun 24
    Reported Aug 8
    		$-0.12N/A+58.62%Beat+52.0%
    Mar 24
    Reported May 9
    		$-0.19$-0.28+32.14%Beat+52.5%
    Dec 23
    Reported Mar 4
    		$-0.35$-0.22-59.09%Miss-45.8%
    Sep 23
    Reported Nov 9
    		$-0.28$-0.34+17.65%Beat+28.2%
    Jun 23
    Reported Aug 9
    		$-0.25$-0.35+28.57%Beat+62.7%
    Mar 23
    Reported May 15
    		$-0.40$-0.27-48.15%Miss+40.3%
    Dec 22
    Reported Mar 16
    		$-0.24$-0.25+4.00%Beat+41.5%
    Sep 22
    Reported Nov 9
    		$-0.39$-0.62+37.10%Beat+40.0%
    Jun 22
    Reported Aug 8
    		$-0.67$-0.72+6.94%Beat-42.6%
    Mar 22
    Reported May 9
    		$-0.67$-0.58-15.52%Miss-19.6%
    Dec 21
    Reported Mar 3
    		$-0.41$-0.52+21.15%Beat+47.4%
    Sep 21
    Reported Nov 8
    		$-0.65$-0.59-10.17%Miss+88.1%
    Jun 21
    Reported Aug 5
    		$-0.47$-0.59+20.34%Beat+96.6%
    Mar 21
    Reported May 5
    		$-0.56$-0.33-69.70%Miss-31.8%
    Dec 20
    Reported Mar 10
    		$-0.78$-0.52-50.00%Miss-83.6%
    Sep 20
    Reported Nov 9
    		$-5.44$-0.64-750.00%Miss-0.0%
    Jun 20
    Reported Aug 26
    		$-13.70$0.00N/AMiss-4041.5%
    Mar 20
    Reported Jun 30
    		$-0.42$0.00N/AMiss-28.4%
    Dec 19
    Reported Mar 30
    		$-0.42$0.00N/AMiss-
    Jun 19
    Reported Sep 30
    		$-5.44$0.00N/AMiss-
    Mar 19
    Reported Jun 29
    		$-0.33$0.00N/AMiss-
    Dec 18
    Reported Mar 30
    		$-0.33$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-26.70EV/EBITDA-1.05x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin57.60%Operating Margin12.90%
    ROE35.70%ROIC102.66%
    Financial Health
    Debt/Equity0.25xInterest CoverageN/A
    Current Ratio2.39xQuick Ratio1.13x
    Trading Statistics
    Beta0.88Avg Volume208.53K
    52-Week High$12.9452-Week Low$4.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$8.60
    SMA 20$7.60
    SMA 50$6.48
    SMA 200$8.37
    EMA 10$8.34
    EMA 20$7.78
    EMA 50$6.93
    EMA 200$8.04

    MACD

    Line: 0.72Signal: 0.71Hist: 0.01

    ADX

    ADX: 45.7+DI: 35.3-DI: 13.7

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down16.0
    PSAR$9.23

    Bollinger Bands

    Upper Band$10.19
    Lower Band$5.02
    %B Position6798%(Upper)
    Band Width0.65

    RSI (14-Day)

    Neutral
    63.9

    Momentum Oscillators

    Stoch %K73.8
    Stoch %D78.3
    Williams %R-26.9
    ROC (10d)3.7%
    Momentum0.30
    CCI (20d)46.0
    MFI (14d)86.5

    Volatility Measures

    ATR (14d)$0.42(5.0%)
    StdDev (20d)1.29
    Hist Vol120.0%(High)

    Volume Flow

    VWAP$8.39
    OBV-3.5M
    AD Line-5.5M
    CMF (20d)0.211

    Volume Metrics

    Avg Vol (20d)216.6K
    Vol Ratio0.4x(Low)
    VWMA (20d)$8.20

    Pivot Points

    R3$8.76
    R2$8.64
    R1$8.47
    Pivot Point$8.35
    S1$8.18
    S2$8.06
    S3$7.89

    Advanced Oscillators

    TSI40.69
    Ultimate Osc56.7
    KST477.03

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$16.50M$13.43M$16.02M$14.32M$13.94M$14.16M$16.73M$13.54M$12.64M$10.59M$12.11M$9.79M
    Cost of Revenue$6.72M$7.05M$9.09M$8.28M$6.91M$7.03M$9.62M$7.27M$5.82M$4.92M$6.96M$4.92M
    Gross Profit$9.78M$6.38M$6.94M$6.04M$7.02M$7.13M$7.11M$6.27M$6.81M$5.66M$5.15M$4.88M
    Operating Expenses$7.64M$4.14M$11.86M$13.62M$13.31M$12.91M$8.40M$7.51M$12.09M$8.51M$8.11M$6.92M
    R&D$1.27M$1.39M$1.30M$1.37M$1.43M$1.53M$1.33M$1.20M$1.35M$1.44M$1.46M$1.53M
    SG&A$6.14M$2.53M$10.33M$12.02M$11.66M$11.15M$6.83M$6.08M$6.78M$6.80M$6.37M$5.12M
    Operating Income$2.13M$2.24M$-4,919,000$-7,580,000$-6,289,000$-5,790,000$-1,290,000$-1,245,000$-5,280,000$-2,850,000$-2,961,000$-2,040,000
    Interest Income$0$10.00M$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$21.71M$17.56M$410,000$3.92M$0$1.20M$0
    Income Before Tax$3.36M$36.33M$-1,609,000$-3,846,000$-1,957,000$-27,504,000$-18,851,000$-1,655,000$-9,203,000$-2,355,000$-4,159,000$2.30M
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$3.54M$36.33M$-1,458,000$-3,713,000$-1,764,000$-27,345,000$-18,702,000$-1,502,000$-9,043,000$-2,157,000$-3,926,000$2.57M
    EBITDA$4.47M$27.46M$-453,000$-2,754,000$-913,000$-26,475,000$-17,810,000$-714,000$-8,374,000$-1,485,000$-3,247,000$3.19M
    EBIT$3.36M$26.33M$-1,609,000$-3,846,000$-1,957,000$-27,504,000$-18,851,000$-1,655,000$-9,203,000$-2,355,000$-4,159,000$2.30M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LNSR

    News

    BTIG Maintains LENSAR(LNSR.US) With Buy Rating, Raises Target Price to $10

    BTIG has reiterated its Buy rating on LENSAR (LNSR.US) and increased its target price to $10. This revised target suggests a potential upside of 112.77% from the stock's last closing price, indicating strong confidence in the company's future performance. The analyst's decision reflects a positive outlook for LENSAR's valuation and growth prospects.

    Moomoo•8/21/26•
    Bullish

    LNSR Maintains Buy Rating by BTIG -- Price Target Raised to $10.

    BTIG has maintained a Buy rating for LENSAR (LNSR) and increased its price target from $9.00 to $10.00, reflecting confidence in the company's growth potential within the medical devices sector. Despite this positive analyst outlook, LENSAR is considered significantly overvalued with a GF Value™ of $4.91 compared to its current price of $8.72, and its low profitability rank raises concerns for investors. Gurus are adding positions, suggesting some positive sentiment, but caution is advised due to the valuation and unprofitability.

    GuruFocus•8/20/26•
    Somewhat-Bullish

    LNSR Looks 65.7% Overvalued on GF Value™

    LENSAR Inc (LNSR) is set to discuss strategic updates at a virtual meeting on August 20, 2026. Despite a high Price-to-Sales ratio (2.0x) and being unprofitable, two prominent gurus have added to their positions. GuruFocus’ GF Value™ indicates LNSR is 65.7% overvalued, yet its GF Score™ of 67/100 reflects strong growth potential despite profitability and valuation concerns.

    GuruFocus•8/16/26•
    Somewhat-Bearish

    Trading the Move, Not the Narrative: (LNSR) Edition

    This article provides an AI-generated analysis of Lensar Inc. (NASDAQ: LNSR), highlighting a strong near and mid-term sentiment but a weak long-term outlook. It indicates a breakout is underway with compelling upside potential due to no resistance levels remaining above the current price. The analysis includes specific institutional trading strategies (Position, Momentum Breakout, Risk Hedging) with entry zones, targets, and stop losses, alongside multi-timeframe signal analysis for support and resistance levels.

    Stock Traders Daily•8/16/26•
    Somewhat-Bullish

    LENSAR (NASDAQ:LNSR) Upgraded at Wall Street Zen

    Wall Street Zen upgraded LENSAR (NASDAQ:LNSR) from "sell" to "hold," aligning with the overall analyst consensus of "Hold" and an $11.00 price target. This upgrade follows LENSAR's positive quarterly earnings, which surpassed revenue and EPS expectations. The company also saw increased institutional investment and continued demand for its ALLY systems.

    MarketBeat•8/15/26•
    Bullish

    Frequently Asked Questions About LNSR

    Does LNSR pay dividends?
    LENSAR Inc (LNSR) does not currently pay a regular dividend.
    What is LNSR's market cap?
    LENSAR Inc (LNSR) has a market capitalization of $103.08M with a current stock price of $8.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In